Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.
Authors: Lee HJ; Yonsei University College of Medicine, Seoul, Republic of Korea. shinji@yuhs.ac., Jeong GH, Li H, Kim MS, Kim JS, Park SJ, Han YJ, Lee KH, Kronbichler A, Hong SH, Ghayda RA, Luchini C, Nottegar A, Koyanagi A, Smith L, Jacob L, Dragioti E, Radua J, Cargnin S, Terrazzino S, Thompson T, Yon DK, Lee SW, Yang JM, Wasuwanich P, Shin JI, Gamerith G
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Oct; Vol. 25 (20), pp. 6232-6244.
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729
DOI:10.26355/eurrev_202110_26993